Lexington

Gambling.com Group Ready for Launch of Online Sports Betting in Kentucky with BetKentucky.com

Retrieved on: 
Wednesday, September 27, 2023

Kentucky -- with a population of over three million adults -- launched retail sports betting in the state on September 7, with Governor Andy Beshear announcing brick-and-mortar sportsbooks posted a handle of over $4.5 million after the first two weekends. BetKentucky.com in late July commissioned a survey, reporting that 42% of Kentucky adults say they are “very likely” or “likely” to bet on sports once it is legalized. Kentucky has a strong college sporting history with college teams at the University of Kentucky, University of Louisville and others receiving undivided attention from fans across the state.

Key Points: 
  • Gambling.com Group Limited (Nasdaq: GAMB) (“Gambling.com Group” or the “Group”), a leading provider of player acquisition services for the regulated global online gambling industry, today announced that it is ready to provide marketing services to licensed online sports betting operators in the state of Kentucky as legal online sports betting goes live on Thursday, September 28, 2023.
  • The Group launched BetKentucky.com in April 2022 ahead of the legal online sports betting market in Kentucky going live to help sports bettors find trusted, comprehensive and up-to-date information on sports betting and legislative updates in the Bluegrass State.
  • Through its portfolio of informational websites, Gambling.com Group helps operators acquire players, reducing their reliance on more intrusive forms of advertising.
  • Kentucky has a strong college sporting history with college teams at the University of Kentucky, University of Louisville and others receiving undivided attention from fans across the state.

Breezeline Employees Plant Trees in Eight States in Support of the Environment and Local Communities

Retrieved on: 
Saturday, September 24, 2022

Inspired by the theme "Planting Roots in Our Communities," Breezeline employees planted trees today at multiple locations in Connecticut, Florida, Maryland, Massachusetts, New Hampshire, Ohio, Pennsylvania, South Carolina, and Virginia.

Key Points: 
  • Inspired by the theme "Planting Roots in Our Communities," Breezeline employees planted trees today at multiple locations in Connecticut, Florida, Maryland, Massachusetts, New Hampshire, Ohio, Pennsylvania, South Carolina, and Virginia.
  • The tree planting activities further the companys commitment to the environment, while helping to beautify local communities with all of the benefits trees provide.
  • "We are committed to actions which have a positive environmental impact," said Frank van der Post, President of Breezeline.
  • Trees were sourced from local nurseries, with species selected for adaptability with local climates, including Central Nursery and Prides Corner (CT), Wentworth Greenhouses (Rollinsford, NH).

Horse Slaughter and Soring Debate Continue with Congressional Hearing on PAST and SAFE Acts Today

Retrieved on: 
Thursday, May 26, 2022

SAFE would bring an end to the gruesome trade in horse meat and the slaughter of American equines shipped to Mexico and Canada some 23,000 of them in 2021.

Key Points: 
  • SAFE would bring an end to the gruesome trade in horse meat and the slaughter of American equines shipped to Mexico and Canada some 23,000 of them in 2021.
  • And we also have the opportunity to end the abusive practice of horse soring.
  • Its time to align our deep love and respect for our equines with federal law by passing the SAFE Act.
  • The opportunity to make revisions to PAST still remains with Tennessee Walking Horse leaders who have conceded soring must end.

Federal Judge Dismisses Lawsuit, Upholds Horseracing Integrity and Safety Act

Retrieved on: 
Friday, April 1, 2022

LUBBOCK, TEXAS, April 01, 2022 (GLOBE NEWSWIRE) -- Texas Judge James Wesley Hendrix has just dismissed a lawsuit initiated by the National Horsemen's Benevolent and Protective Association (NHBPA) last year, an attempt to derail the Horseracing Integrity and Safety Act (HISA) that takes effect in July of 2022.

Key Points: 
  • LUBBOCK, TEXAS, April 01, 2022 (GLOBE NEWSWIRE) -- Texas Judge James Wesley Hendrix has just dismissed a lawsuit initiated by the National Horsemen's Benevolent and Protective Association (NHBPA) last year, an attempt to derail the Horseracing Integrity and Safety Act (HISA) that takes effect in July of 2022.
  • Its time for the Horseracing Integrity and Safety Authority to swiftly implement the new law as intended and secure a contract with the U.S. Anti-Doping Agency to oversee all testing and enforcement so the eradication of doping can begin.
  • We congratulate the Authority on this tremendous victory leading up to the running of the 148th Kentucky Derby.
  • AWA's recent written works on the issue in the Lexington Herald-Leader and Horse Nation have urged the new Horseracing Integrity and Safety Authority to secure a contract with the U.S. Anti-Doping Agency (USADA) as the Congress intended.

Gambling.com Group and McClatchy Sign Strategic Sports Betting Partnership

Retrieved on: 
Tuesday, January 18, 2022

By partnering with Gambling.com Group, McClatchy gains access to the Group's proprietary data science platform, award winning sports betting content team and leading expertise in how to monetize online sports betting traffic.

Key Points: 
  • By partnering with Gambling.com Group, McClatchy gains access to the Group's proprietary data science platform, award winning sports betting content team and leading expertise in how to monetize online sports betting traffic.
  • Gambling.com Group will help McClatchy leverage its audience reach and provide highly valuable content to capture and monetize valuable high-intent traffic.
  • "The proliferation of online sports betting across the U.S. provides an opportunity for McClatchy to increase their monetization of real money gaming.
  • I am delighted to announce our first media partnership is with such a significant and authoritative media organization as McClatchy.

A&W Restaurants Celebrates 10 Years Under Franchisee Ownership

Retrieved on: 
Friday, December 10, 2021

Brands control, said Kevin Klein, chairman of the National A&W Franchisee Association (NAWFA), which is a significant partner.

Key Points: 
  • Brands control, said Kevin Klein, chairman of the National A&W Franchisee Association (NAWFA), which is a significant partner.
  • Being under franchisee ownership allowed us to control our own destiny, which was thrilling and scary at the same time.
  • Klein noted that franchisee ownership also has created stability that is unusual in the chain restaurant industry.
  • When we are at board meetings, state franchisee meetings or conventions, there are always more hugs than handshakes.

uniQure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B

Retrieved on: 
Thursday, December 9, 2021

LEXINGTON, Mass. and AMSTERDAM, The Netherlands and KING OF PRUSSIA, Pa., Dec. 09, 2021 (GLOBE NEWSWIRE) -- CSL Behring, a global biotherapeutics leader, and uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that etranacogene dezaparvovec, an investigational adeno-associated virus five (AAV5)-based gene therapy for the treatment of patients with severe to moderately severe hemophilia B, achieved the pre-specified primary endpoint of non-inferiority in annualized bleeding rate (ABR) 18-months following administration compared to baseline Factor IX (FIX) prophylactic therapy in the pivotal Phase III HOPE-B gene therapy trial. The study also successfully achieved a secondary endpoint demonstrating statistical superiority in reduction of ABR compared to baseline FIX prophylactic therapy.

Key Points: 
  • The study also successfully achieved a secondary endpoint demonstrating statistical superiority in reduction of ABR compared to baseline FIX prophylactic therapy.
  • We are very pleased with these top-line results from what is the largest and first pivotal trial of a gene therapy for patients with hemophilia B, stated Ricardo Dolmetsch , Ph.D., president of research and development at uniQure.
  • On behalf of uniQure, we extend our heartfelt gratitude to all the HOPE-B clinical trial patients and their families, as well as the trial investigators, he continued.
  • A total of 54 patients received a single dose of etranacogene dezaparvovec in the pivotal trial, with 53 patients completing at least 18 months of follow-up.

Mimecast Integrates with Secureworks Taegis XDR to Better Protect Email from Threat Actors, Securing Customers’ Communications and Data

Retrieved on: 
Tuesday, December 7, 2021

Mimecasts extensible architecture is now integrated into Taegis XDR, which combines threat intelligence across cloud, network, and endpoints to detect threats.

Key Points: 
  • Mimecasts extensible architecture is now integrated into Taegis XDR, which combines threat intelligence across cloud, network, and endpoints to detect threats.
  • This maximizes our customers investments in Mimecast and provides the rapid detection and response capabilities that keep customers safe.
  • Email is a primary target for threat actors, and a front door for organizational data that must be protected.
  • By centralizing threat data from email, endpoint, network and cloud into a scalable data lake, joint customers can take advantage of the Taegis XDR advanced search query language to better thwart threat actor intent and behavior.

Mimecast to Become a Private Company through Transaction with Permira Valued at Approximately $5.8 Billion

Retrieved on: 
Tuesday, December 7, 2021

Under the terms of the agreement, Permira will acquire all outstanding ordinary shares of Mimecast for $80.00 per share in an all-cash transaction that values Mimecast at an equity value of approximately $5.8 billion.

Key Points: 
  • Under the terms of the agreement, Permira will acquire all outstanding ordinary shares of Mimecast for $80.00 per share in an all-cash transaction that values Mimecast at an equity value of approximately $5.8 billion.
  • Today is an exciting milestone for Mimecast as we begin a new chapter for our company, said Peter Bauer, chairman and chief executive officer of Mimecast.
  • We have long admired Mimecast, its management team and its talented employees, said Permira Partners, Michail Zekkos and Ryan Lanpher.
  • Upon completion of the transaction, Mimecast will become a privately held company and the ordinary shares of Mimecast will no longer be listed on any public market.

Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions

Retrieved on: 
Monday, December 6, 2021

The collaboration is designed to explore the potential for Microbiome Metabolic Therapies (MMT) to prevent childhood-onset of atopic, immune and metabolic conditions by promoting healthy function of the gut microbiome.

Key Points: 
  • The collaboration is designed to explore the potential for Microbiome Metabolic Therapies (MMT) to prevent childhood-onset of atopic, immune and metabolic conditions by promoting healthy function of the gut microbiome.
  • Janssen will fund the additional costs associated with the expanded scope of the collaboration.
  • The Company has built a proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT).
  • Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs.